PAD

亜型選択性的な製品

PAD製品

All (3)
PAD阻害剤 (3)
新製品

製品コード	製品名称	製品説明	文献中Selleckの製品使用例	お客様のフィードバック
S8141	Cl-amidine	Cl-amidine is an irreversible pan-peptidylarginine deiminase (PAD) inhibitor with IC50 values of 5.9 ± 0.3 μM, 0.8 ± 0.3 μM, 6.2 ± 1.0 μM for PAD4, PAD1 and PAD3, respectively. Cl-amidine induces apoptosis.	Heliyon, 2024, 10(1):e23633 Cell Discov, 2023, 9(1):104 Cell Discov, 2023, 9(1):104
S7803	GSK484 HCl	GSK484 HCl, a benzoimidazole derivative, is a selective and reversible inhibitor of peptidylarginine deiminase 4 (PAD4) with IC50 of 50 nM in the absence of Calcium.	Cell Discov, 2023, 9(1):104 Cell Discov, 2023, 9(1):104 Phytomedicine, 2021, 90:153635
S9644	BMS-P5	BMS-P5, a potent selective pharmacological inhibitor of PAD4, is used to evaluate the effect of PAD4 inhibition on multiple myeloma (MM)-induced neutrophil extracellular trap (NET) formation.
S8141	Cl-amidine	Cl-amidine is an irreversible pan-peptidylarginine deiminase (PAD) inhibitor with IC50 values of 5.9 ± 0.3 μM, 0.8 ± 0.3 μM, 6.2 ± 1.0 μM for PAD4, PAD1 and PAD3, respectively. Cl-amidine induces apoptosis.	Heliyon, 2024, 10(1):e23633 Cell Discov, 2023, 9(1):104 Cell Discov, 2023, 9(1):104
S7803	GSK484 HCl	GSK484 HCl, a benzoimidazole derivative, is a selective and reversible inhibitor of peptidylarginine deiminase 4 (PAD4) with IC50 of 50 nM in the absence of Calcium.	Cell Discov, 2023, 9(1):104 Cell Discov, 2023, 9(1):104 Phytomedicine, 2021, 90:153635
S9644	BMS-P5	BMS-P5, a potent selective pharmacological inhibitor of PAD4, is used to evaluate the effect of PAD4 inhibition on multiple myeloma (MM)-induced neutrophil extracellular trap (NET) formation.

PAD阻害剤の選択性比較

Tags: PAD inhibitor|PAD agonist|PAD activator|PAD inducer|PAD antagonist|PAD signaling pathway|PAD assay kit